Pantoprazol Carinopharm (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Carinopharm, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Carinopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Carinopharm is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates healing of erosive lesions in the oesophagus. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Pantoprazol Carinopharm may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring intermittently. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of face or throat. - Clostridioides difficile infection: persistent watery diarrhoea with abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme abnormalities: elevated ALT/AST indicating hepatic stress.

When prescribing Pantoprazol Carinopharm, clinicians should consider several safety aspects. - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for reduced efficacy of drugs needing acidic pH. - Monitor long‑term use: evaluate risk of bone density loss and vitamin B12 deficiency. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with the lowest effective dose and monitor for adverse effects. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Carinopharm can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to loss of antifungal efficacy. - Atazanavir: markedly decreased plasma concentrations, compromising HIV treatment. - Clopidogrel: diminished activation, potentially reducing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent coagulation monitoring. - Digoxin: slight increase in serum levels, warranting periodic level checks. - Methotrexate: elevated exposure, especially at high doses, may need dose adjustment.